Issue link: https://www.e-digitaleditions.com/i/1417310
This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 28 OctOber 2021 Inhalation Special Section outSourcing ServiceS This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. Development of a range of therapies Vectura is a provider of innovative inhaled drug deliv- ery services. With more than 20 years of experience, the company helps customers succeed in bringing inhaled medicines to market. With differentiated proprietary technology and pharmaceutical devel- opment expertise, Vectura is among the companies globally with the device, formulation and develop- ment capabilities to deliver a broad range of complex inhaled therapies across a variety of platforms includ- ing dry powder inhalers (DPIs), pressurized metered dose inhalers (pMDIs) and smart nebulizers. Vectura UK: +44 1249 667700 www.vectura.com Clinical development of respiratory drugs and devices Cliantha Research, a global, full service, contract research organization (CRO), specializes in the clin- ical development of respiratory drugs and devices. Cliantha has more than 15 years of experience helping bring many respiratory products to market, through the conduct of high quality, regulatory-ready, clin- ical research studies, Phases I-IV. Cliantha has an exemplary success record with the conduct of phar- macokinetic and pharmacodynamic studies required for generic inhaled products. Fast-track your clinical development pathway with Cliantha Research. Cliantha Research US: +1 507 208-5012 www.cliantha.com Single service or comprehensive development Catalent Inhalation has the capabilities, expertise and state-of-the-art facilities to expedite product development, from concept and feasibility studies through commercial manufacture and release testing. With over 25 years of inhalation product experience, Catalent can handle the most complex projects and help bring therapies to market, faster. Whether a single service or a comprehensive development pack- age is required, Catalent offers turnkey solutions, including analytical and formulation support, for the following dosage forms: metered dose inhalers, dry powder inhalers and nasal sprays. Catalent US: +1 888 SOLUTION (765-8846) www.catalent.com